Latest glioblastoma multiforme Stories
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
- $5.8 million award will help advance the development of oxygen-carrying therapeutics for cancer - SAN CARLOS, Calif., Oct.
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.
VANCOUVER, British Columbia and MENLO PARK, Calif., Oct.
SAN ANTONIO, Sept. 30, 2014 /PRNewswire/ -- GenSpera, Inc.
Completion of Enrollment Expected in 2015; Progression-Free Survival Data Expected in mid-2016 LOS ANGELES, Sept.
SYDNEY, Sept. 29, 2014 /PRNewswire/ -- Novogen Ltd.
Follows CytRx's Strategy to Develop a Global Oncology Franchise in Numerous Orphan Indications LOS ANGELES, Sept.
Analyses of PRiDe, a registry of 457 recurrent glioblastoma patients, show that patients treated with the NovoTTF(TM)-100A System at their first and second recurrences had median overall survivals
- Large; stout; burly.